FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3027638174> ?p ?o ?g. }

• W3027638174 endingPage "165006" @default.
• W3027638174 startingPage "165006" @default.
• W3027638174 abstract "We show the performance and feasibility of a proton arc technique so-called proton monoenergetic arc therapy (PMAT). Monoenergetic partial arcs are selected to place spots at the middle of a target and its potential to enhance the dose-averaged linear energy transfer (LETd) distribution within the target. Single-energy partial arcs in a single 360 degree gantry rotation are selected to deposit Bragg's peaks at the central part of the target to increase LETd values. An in-house inverse planning optimizer seeks for homogeneous doses at the target while keeping the dose to organs at risk (OARs) within constraints. The optimization consists of balancing the weights of spots coming out of selected partial arcs. A simple case of a cylindrical target in a phantom is shown to illustrate the method. Three different brain cancer cases are then considered to produce actual clinical plans, compared to those clinically used with pencil beam scanning (PBS). The relative biological effectiveness (RBE) is calculated according to the microdosimetric kinetic model (MKM). For the ideal case of a cylindrical target placed in a cylindrical phantom, the mean LETd in the target increases from 2.8 keV μm−1 to 4.0 keV μm−1 when comparing a three-field PBS plan with PMAT. This is replicated for clinical plans, increasing the mean RBE-weighted doses to the CTV by 3.1%, 1.7% and 2.5%, respectively, assuming an ratio equal to 10 Gy in the CTV. In parallel, LETd to OARs near the distal edge of the tumor decrease for all cases and metrics (mean LETd, LD,2% and LD,98%). The PMAT technique increases the LETd within the target, being feasible for the production of clinical plans meeting physical dosimetric requirements for both target and OARs. Thus, PMAT increases the RBE within the target, which may lead to a widening of the therapeutic index in proton radiotherapy that would be highlighted for low ratios and hyperfractionated schedules." @default.
• W3027638174 created "2020-05-29" @default.
• W3027638174 creator A5029803856 @default.
• W3027638174 creator A5068621349 @default.
• W3027638174 date "2020-08-19" @default.
• W3027638174 modified "2023-10-02" @default.
• W3027638174 title "Proton monoenergetic arc therapy (PMAT) to enhance LETd within the target" @default.
• W3027638174 cites W1914262973 @default.
• W3027638174 cites W1985750332 @default.
• W3027638174 cites W1989500462 @default.
• W3027638174 cites W1990869665 @default.
• W3027638174 cites W2001265272 @default.
• W3027638174 cites W2005775826 @default.
• W3027638174 cites W2035306925 @default.
• W3027638174 cites W2038133499 @default.
• W3027638174 cites W2041294889 @default.
• W3027638174 cites W2059388843 @default.
• W3027638174 cites W2065480491 @default.
• W3027638174 cites W2066648318 @default.
• W3027638174 cites W2081844303 @default.
• W3027638174 cites W2088348443 @default.
• W3027638174 cites W2094639450 @default.
• W3027638174 cites W2103551282 @default.
• W3027638174 cites W2104358865 @default.
• W3027638174 cites W2118934545 @default.
• W3027638174 cites W2128158076 @default.
• W3027638174 cites W2128881154 @default.
• W3027638174 cites W2144573642 @default.
• W3027638174 cites W2153683941 @default.
• W3027638174 cites W2161674690 @default.
• W3027638174 cites W2163678892 @default.
• W3027638174 cites W2513819086 @default.
• W3027638174 cites W2516454733 @default.
• W3027638174 cites W2530322153 @default.
• W3027638174 cites W2744153187 @default.
• W3027638174 cites W2744169094 @default.
• W3027638174 cites W2764174300 @default.
• W3027638174 cites W2786729345 @default.
• W3027638174 cites W2802172296 @default.
• W3027638174 cites W2898672813 @default.
• W3027638174 cites W2912071408 @default.
• W3027638174 cites W2946000200 @default.
• W3027638174 cites W2952991212 @default.
• W3027638174 cites W2957914865 @default.
• W3027638174 cites W2979302830 @default.
• W3027638174 cites W2995878433 @default.
• W3027638174 cites W3009663086 @default.
• W3027638174 cites W3098202381 @default.
• W3027638174 cites W3137404195 @default.
• W3027638174 doi "https://doi.org/10.1088/1361-6560/ab9455" @default.
• W3027638174 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32428896" @default.
• W3027638174 hasPublicationYear "2020" @default.
• W3027638174 type Work @default.
• W3027638174 sameAs 3027638174 @default.
• W3027638174 citedByCount "19" @default.
• W3027638174 countsByYear W30276381742021 @default.
• W3027638174 countsByYear W30276381742022 @default.
• W3027638174 countsByYear W30276381742023 @default.
• W3027638174 crossrefType "journal-article" @default.
• W3027638174 hasAuthorship W3027638174A5029803856 @default.
• W3027638174 hasAuthorship W3027638174A5068621349 @default.
• W3027638174 hasConcept C104293457 @default.
• W3027638174 hasConcept C111337013 @default.
• W3027638174 hasConcept C11928243 @default.
• W3027638174 hasConcept C120665830 @default.
• W3027638174 hasConcept C121332964 @default.
• W3027638174 hasConcept C185544564 @default.
• W3027638174 hasConcept C192562407 @default.
• W3027638174 hasConcept C2524010 @default.
• W3027638174 hasConcept C2775881188 @default.
• W3027638174 hasConcept C2779244869 @default.
• W3027638174 hasConcept C2780944729 @default.
• W3027638174 hasConcept C2989005 @default.
• W3027638174 hasConcept C30475298 @default.
• W3027638174 hasConcept C33923547 @default.
• W3027638174 hasConcept C54516573 @default.
• W3027638174 hasConcept C71924100 @default.
• W3027638174 hasConcept C83415579 @default.
• W3027638174 hasConcept C86611320 @default.
• W3027638174 hasConceptScore W3027638174C104293457 @default.
• W3027638174 hasConceptScore W3027638174C111337013 @default.
• W3027638174 hasConceptScore W3027638174C11928243 @default.
• W3027638174 hasConceptScore W3027638174C120665830 @default.
• W3027638174 hasConceptScore W3027638174C121332964 @default.
• W3027638174 hasConceptScore W3027638174C185544564 @default.
• W3027638174 hasConceptScore W3027638174C192562407 @default.
• W3027638174 hasConceptScore W3027638174C2524010 @default.
• W3027638174 hasConceptScore W3027638174C2775881188 @default.
• W3027638174 hasConceptScore W3027638174C2779244869 @default.
• W3027638174 hasConceptScore W3027638174C2780944729 @default.
• W3027638174 hasConceptScore W3027638174C2989005 @default.
• W3027638174 hasConceptScore W3027638174C30475298 @default.
• W3027638174 hasConceptScore W3027638174C33923547 @default.
• W3027638174 hasConceptScore W3027638174C54516573 @default.
• W3027638174 hasConceptScore W3027638174C71924100 @default.
• W3027638174 hasConceptScore W3027638174C83415579 @default.
• W3027638174 hasConceptScore W3027638174C86611320 @default.
• W3027638174 hasFunder F4320309603 @default.

• next